New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
OverviewChart

Quote Panel

Shape
Updated April 27, 2025
1W % 1M % 3M % 1Y %

Key Metrics

Shape

  • Market Cap

  • Shares Outstanding

  • Share in Float

  • Dividende

  • Earning Date

    No Data

  • Price Target

  • Average Volume

  • Beta

  • Range

  • Industry

  • Website

  • Sector

Fundamentals

Shape

Relative Strength

Shape

PYPD

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-8.41
vs -18.92

Q2.23

arrow
arrow

N/A

-3.90
vs -18.32

Q3.23

arrow
arrow

N/A

-3.40
vs -14.41

Q4.23

arrow
arrow

N/A

-3.97
vs -9.61

Q1.24

arrow
arrow

N/A

-1.37
vs -8.41

Q2.24

arrow
arrow

N/A

-1.25
vs -3.90

Q3.24

arrow
arrow

N/A

-1.22
vs -3.40

Q4.24

arrow
arrow

N/A

NA
vs -3.97

Q1.25

arrow
arrow

N/A

-0.88
vs -1.37

Q2.25

arrow
arrow

N/A

-0.69
vs -1.25

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

NA  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Q3.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-53%

-0.53
vs -1.11

Q2.23

arrow
arrow

-70%

-0.70
vs -0.53

Q3.23

arrow
arrow

-158%

-1.58
vs -0.70

Q4.23

arrow
arrow

+303%

3.03
vs -1.58

Q1.24

arrow
arrow

-90%

-0.90
vs 3.03

Q2.24

arrow
arrow

-393%

-3.93
vs -0.90

Q3.24

arrow
arrow

-360%

-3.60
vs -3.93

Q4.24

arrow
arrow

-111%

-1.11
vs -3.60

Institutionnal OwnershipShape

status-upQoQ

Q3.21

arrow
arrow

19

19
vs 22

-14%

Q4.21

arrow
arrow

30

30
vs 19

58%

Q1.22

arrow
arrow

31

31
vs 30

3%

Q2.22

arrow
arrow

30

30
vs 31

-3%

Q3.22

arrow
arrow

21

21
vs 30

-30%

Q4.22

arrow
arrow

14

14
vs 21

-33%

Q1.23

arrow
arrow

10

10
vs 14

-29%

Q2.23

arrow
arrow

13

13
vs 10

30%

Earnings Growth

Latest News

PYPD

globenewswire.com

7 hours ago

PolyPid to Participate in The Citizens Life Sciences Conference
PYPD

globenewswire.com

7 hours ago

PolyPid Announces Successful Completion of Enrollment in Phase 3 SHIELD II Trial of D-PLEX₁₀₀ for the Prevention of Abdominal Colorectal Surgical Site Infections
PYPD

globenewswire.com

7 hours ago

PolyPid to Participate in the 37th Annual ROTH Conference
PYPD

globenewswire.com

7 hours ago

PolyPid Provides Corporate Update and Reports Fourth Quarter and Full-Year 2024 Financial Results
PYPD

globenewswire.com

7 hours ago

PolyPid to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference
PYPD

seekingalpha.com

10 hours ago

PolyPid Ltd. (PYPD) Q4 2024 Earnings Call Transcript